ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 72 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,153,000 | +3.3% | 68,213 | +0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,116,000 | +8.1% | 68,023 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $1,032,000 | +43.3% | 68,141 | +36.9% | 0.00% | 0.0% |
| Q1 2016 | $720,000 | -37.6% | 49,776 | +22.3% | 0.00% | 0.0% |
| Q4 2015 | $1,153,000 | +70.1% | 40,708 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $678,000 | -34.0% | 40,504 | +3.4% | 0.00% | 0.0% |
| Q2 2015 | $1,027,000 | +584.7% | 39,158 | +356.9% | 0.00% | – |
| Q1 2015 | $150,000 | +1.4% | 8,570 | +0.7% | 0.00% | – |
| Q4 2014 | $148,000 | -6.3% | 8,512 | 0.0% | 0.00% | – |
| Q3 2014 | $158,000 | +11.3% | 8,512 | +9.4% | 0.00% | – |
| Q2 2014 | $142,000 | – | 7,781 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |